High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children

201914 citationsJournal Articlegreen Open Access

Authors

Sarah Benki‐Nugent · Center for Global Health

Ira Martopullo · University of Washington

Tony Laboso · University of Nairobi

Nancy Tamasha · University of Nairobi

Dalton Wamalwa · University of Nairobi

Kenneth Tapia · Center for Global Health

Agnes Langat ·

Abstract

Before ART, monocyte activation may reflect transient neuroprotective mechanisms in infants. After ART and viral suppression, monocyte activation may predict worse short- and long-term neurodevelopment outcomes.

Topics & Keywords

HIV Research and Treatment Neonatal and fetal brain pathology Infant Nutrition and Health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAIDS Journal of Acquired Immune Deficiency Syndromes

Volume 81, Issue 1, pp. 102-109

DOI: 10.1097/qai.0000000000001979

Field-Weighted Citation Impact: 1.02